Does BIFIDOBACTERIUM LONGUM Cause Off label use? 93 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 93 reports of Off label use have been filed in association with BIFIDOBACTERIUM LONGUM. This represents 66.4% of all adverse event reports for BIFIDOBACTERIUM LONGUM.
93
Reports of Off label use with BIFIDOBACTERIUM LONGUM
66.4%
of all BIFIDOBACTERIUM LONGUM reports
0
Deaths
92
Hospitalizations
How Dangerous Is Off label use From BIFIDOBACTERIUM LONGUM?
Of the 93 reports, 92 (98.9%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIFIDOBACTERIUM LONGUM. However, 93 reports have been filed with the FAERS database.
What Other Side Effects Does BIFIDOBACTERIUM LONGUM Cause?
Abdominal pain (58)
Malaise (58)
Anaemia (57)
Chronic sinusitis (57)
Colitis (57)
Constipation (57)
Drug ineffective (57)
Erythema (57)
Female genital tract fistula (57)
Frequent bowel movements (57)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BIFIDOBACTERIUM LONGUM Alternatives Have Lower Off label use Risk?
BIFIDOBACTERIUM LONGUM vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
BIFIDOBACTERIUM LONGUM vs BILASTINE
BIFIDOBACTERIUM LONGUM vs BIMATOPROST
BIFIDOBACTERIUM LONGUM vs BIMATOPROST\TIMOLOL
BIFIDOBACTERIUM LONGUM vs BIMEKIZUMAB